Medical Device Change(s), Analysis and 510(k) Impact
Tuesday, November 19, 2013 from 10:00 AM to 11:30 AM (PST)
This 90-minute webinar will provide valuable assistance to all regulated companies performing and documenting meaningful, results driven 510(k) / change analysis activities, based on the FDA's new Draft Guidance, "510(k) Device Modifications: Deciding When to Submit a 510(k) for a Change to an Existing Device", dated July 27, 2011.
Why Should You Attend:
Control of medical device changes and a current 510(k) are big issues in recent FDA studies. Companies are held fully responsible for deciding when a new 510(k) filing is warranted. Often this is a difficult decision process. Effective change control and the power of current risk management tools must be a major part of such an analysis.
The U.S. FDA has its current K-97-1 Memorandum and has published a New Draft Guidance Document, "510(k) Device Modifications: Deciding When to Submit a 510(k) for a Change to an Existing Device", on July 27, 2011, which provides companies tools to perform meaningful, results driven 510(k) / change analysis activities. This is part of a growing push by the Agency to strengthen the 510(k) process. The addition of simple tools will assist companies in implementing formal, documented, repeatable methods with defensible rationale for their decisions on when a new 510(k) needs submission.
This webinar will provide valuable guidance to regulated companies in development and implementation of formal, defined, documented methods for analysis of product changes and when to file a new 510(k). Consideration of the U.S . FDA's current K-97-1 Memo as well as their new draft guidance document, "510(k) Device Modifications: Deciding When to Submit a 510(k) for a Change to an Existing Device", will provide tools to document such decisions. It will also prepare the industry for further 510(k) changes in the future.
Areas Covered in the Seminar:
- Current Requirements of the K 97-1 Memorandum, and FDA Expectations
- Expected sources of information for evaluation and inclusion
- Two approaches to the use of FDA's K97-1 Memo
- Change reporting "tipping point" -- with one change or cumulative
- Step-by-step analysis: Manufacturing, Labeling, Tech / Performance, and/or Materials Changes
- Which of the three major 510(k) formats should be used
- How to complete, document and control as a 'living' document
At ComplianceOnline, we are focused on :
- Enhancing global compliance, creating a world where quality and compliance professionals, regulators, and government agencies come together to help the world comply with the intent and the spirit of laws, policies and mandates, ensuring continuous improvement in global operations, quality & safety.
- Making sure that we are responsible corporate citizens helping our constituents build a more responsible enterprise, one which operates with high quality , under a code of ethics, and with process discipline to ensure greater shareholder returns.
- Keeping things simple and straight forward , so that we all can indeed improve the quality of our processes, our work, our businesses and enhance compliance globally.
- Being inclusive, giving the process experts ( & novices! ), compliance professionals, quality champions, and regulatory agencies a voice so that all of us can contribute and make a difference.